C4 Therapeutics CCCC
NASDAQ CCCC
$2.95 -0.19 (-6.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

C4 Therapeutics (CCCC) Cash & Current Investments (2019 - 2026)

Updated

C4 Therapeutics (CCCC) recorded Cash & Current Investments of $253.66 million in Q2 2026, up 18.2% from $214.55 million a year earlier and up 7.6% from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, C4 Therapeutics reported Cash & Current Investments of $248.54 million, up 1.5% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -7.7% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $244.9 million in FY2024 (-3.5%), $253.68 million in FY2023 (-8.1%), $276.15 million in FY2022 (-10.7%) and $309.28 million in FY2021 (-16.8%).
  • The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q3 2024.
  • On a year-over-year basis, Cash & Current Investments has increased for three consecutive quarters, with an average decline of 2.1% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 101.6% in Q3 2021, against a decline of 33.9% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $235.67 million (Q1 2026), $248.54 million (Q4 2025) and $191.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 C4 Therapeutics 362.57 Mn -567.18 Mn - 253.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 253.66 Mn
Mar 31, 2026 235.67 Mn
Dec 31, 2025 248.54 Mn
Sep 30, 2025 191.88 Mn
Jun 30, 2025 214.55 Mn
Mar 31, 2025 215.09 Mn
Dec 31, 2024 244.90 Mn
Sep 30, 2024 255.64 Mn
Jun 30, 2024 264.10 Mn
Mar 31, 2024 258.19 Mn
Dec 31, 2023 253.68 Mn
Sep 30, 2023 216.57 Mn
Jun 30, 2023 267.29 Mn
Mar 31, 2023 270.33 Mn
Dec 31, 2022 276.15 Mn
Sep 30, 2022 313.65 Mn
Jun 30, 2022 307.78 Mn
Mar 31, 2022 291.17 Mn
Dec 31, 2021 309.28 Mn
Sep 30, 2021 402.07 Mn
API Access

C4 Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CCCC&period=max&api_key=YOUR_API_KEY